Reproductive outcomes, as well as safety and efficacy, between these two treatment approaches are thought to be similar [8,17-20] and GnRH-antagonists have joined alongside GnRH-a as mainstream therapeutic agents used widely at infertility units worldwide. This evidence concerns the gene GNRH1 and Infertility.